Accessibility Menu
 
Neurotech International logo

Neurotech International

(ASX) NTI

Current Price$0.01
Market Cap$15.81M
Since IPO (2016)-95%
5 Year-81%
1 Year-52%
1 Month-8%

Neurotech International Financials at a Glance

Market Cap

$15.81M

Revenue (TTM)

$2.41M

Net Income (TTM)

$15.64M

EPS (TTM)

$-0.00

P/E Ratio

-3.24

Dividend

$0.00

Beta (Volatility)

-0.23 (Low)

Price

$0.01

Volume

155,313

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.03

NTI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neurotech International

Industry

Healthcare Equipment and Supplies

CEO

Anthony Filippis, PhD, MBA

Headquarters

Nedlands, WA 6009, AU

NTI Financials

Key Financial Metrics (TTM)

Gross Margin

3%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

-66%

Return on Capital

-58%

Return on Assets

-57%

Earnings Yield

-30.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.81M

Shares Outstanding

1.32B

Volume

155.31K

Avg. Volume

1.36M

Financials (TTM)

Gross Profit

$2.44M

Operating Income

$11.09M

EBITDA

$10.74M

Operating Cash Flow

$9.02M

Capital Expenditure

$0.00

Free Cash Flow

$9.02M

Cash & ST Invst.

$3.03M

Total Debt

$0.00

Neurotech International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$15.81M

N/A

Market Cap/Employee

$878.49K

N/A

Employees

18

N/A

Net Income

$696.50K

+4.4%

EBITDA

$5.43M

-39.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$6.34M

+41.6%

Accounts Receivable

$375.08K

+99.6%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-56.54%

N/A

Return on Invested Capital

-57.51%

N/A

Free Cash Flow

$38.33K

+95.6%

Operating Cash Flow

$38.33K

+95.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BTC.AXBTC Health Limited
$0.05+0.00%
AGH.AXAlthea Group Holdings Limited
$0.02-4.76%
MDR.AXMedAdvisor Limited
$0.02+0.00%
TRU.AXTruScreen Group Limited
$0.02+6.67%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$16.10+0.04%
AAPLApple
$271.35+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About NTI

What is the current price of Neurotech International?

Neurotech International is trading at A$0.01 per share.

What is the 52-week range for Neurotech International?

Over the past 52 weeks, Neurotech International has traded between A$0.01 and A$0.03.

How much debt does Neurotech International have?

As of the most recent reporting period, Neurotech International reported total debt of N/A.

How much cash does Neurotech International have on hand?

Neurotech International reported $3.03M in cash and cash equivalents in its most recent financial results.

What is Neurotech International’s dividend yield?

Neurotech International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.